SCHEMBL4648563

SCHEMBL4648563

Cc1cc(-c2ccccc2)[c]c(C(C)(C)C)c1

nearest known ligand 0.33

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.33
LMNA P02545 3/20 0.33
ALDH1A1 P00352 3/20 0.33
MAPT P10636 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
CNR1 P21554 2/20 0.31
CNR2 P34972 2/20 0.31
TSHR P16473 1/20 0.31
ALOX12 P18054 1/20 0.31
ACHE P22303 1/20 0.31
SMN1; SMN2 Q16637 2/20 0.30
MCOLN3 Q8TDD5 1/20 0.30
PSMB5 P28074 1/20 0.30
HTT P42858 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
POLB P06746 1/20 0.30
PKM P14618 1/20 0.30
RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7914615 0.82 LMNA (0.41) KDM4ELMNAALDH1A1MAPTMEN1
SCHEMBL6165725 0.82 ALDH1A1 (0.36) ALDH1A1SMN1; SMN2POLB
SCHEMBL7951297 0.81 RXRA (0.37) ALDH1A1MEN1KMT2ACNR1CNR2
SCHEMBL15067592 0.77 ALDH1A1 (0.36) KDM4EALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL195576 0.76 LMNA (0.36) KDM4ELMNAALDH1A1MAPTMEN1
SCHEMBL60651 0.75 ALDH1A1 (0.40) ALDH1A1TSHRSMN1; SMN2POLB
SCHEMBL4648041 0.75 ALDH1A1 (0.32) ALDH1A1MEN1KMT2A
SCHEMBL4648856 0.72 RXRA (0.41) ALDH1A1MEN1KMT2ACNR1CNR2
SCHEMBL4457527 0.70 KDM4E (0.33) KDM4ELMNAALDH1A1MAPTTSHR
SCHEMBL3823195 0.67 ALDH1A1 (0.34) ALDH1A1CNR1CNR2TSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1577314-B1 Catalyst based on a transition metal complex for polymerization of olefins, and process for polymerization of olefins using the catalyst TOSOH CORP (JP) 2008-08-27 EP disclosed
US-7153916-B2 Transition metal compound, catalyst for polymerization of olefin, and process for polymerization of ofelin using the catalyst TOSOH CORPORATION (JP) 2006-12-26 US disclosed
EP-1577314-A1 Catalyst based on a transition metal complex for polymerization of olefin, and process for polymerization of olefin using the catalyst Tosoh Corporation (JP) 2005-09-21 EP disclosed
EP-1241175-B1 Transition metal compound, catalyst for polymerization of olefin, and process for polymerization of olefin using the catalyst TOSOH CORP (JP) 2005-08-31 EP disclosed
US-20030018145-A1 Transition metal compound, catalyst for polymerization of olefin, and process for polymerization of olefin using the catalyst TOSOH CORPORATION (JP) 2003-01-23 US disclosed
EP-1241175-A2 Transition metal compound, catalyst for polymerization of olefin, and process for polymerization of olefin using the catalyst Tosoh Corporation (JP) 2002-09-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030018145-A1 Transition metal compound, catalyst for polymerization of olefin, and process for polymerization of olefin using the catalyst PORCN, OSTC, PPOX KDM4E 3436/4885LMNA 4366/4885ALDH1A1 2770/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.